The goals of this research are to better understand the structure, function and distribution of zinc metalloproteins. The catalytic mechanisms and essential active site features of three medically important and novel classes of zinc metalloenzymes will be elucidated, including carbonic anhydrases, protein prenyltransferases and zinc-dependent deacetylases. In the prototypical zinc enzyme, carbonic anhdrase II, roles of the direct metal ligands and the surrounding metal site for determining high catalytic activity and metal selectivity will be investigated using mutagenesis and selection techniques. For protein farnesyltransferase and geranylgeranyltransferase I, the following will be investigated: the structure and reactivity of the metal sites using spectrosocopic methods, metal substitution and mutagenesis; the structure of the transition state by measuring primary and secondary isotope effect; and interactions with peptide substrates that enhance peptide affinity and reactivity using altered substrates and mutagenesis. For UDP-3- O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC), the structure of the metal site will be elucidated using ENDOR, NMR and X-ray crystallography; the functional role of key conserved amino acids will be determined by characterizing the catalytic properties of mutants; and the catalytic mechanism will be probed using pH variation, solvent isotope effects and transient kinetics. Finally, the distribution of zinc metalloproteins in the yeast proteome will be probed using a powerful new """"""""functional genomics"""""""" technology. Carbonic anhydrase-based sensors will be developed to rapidly and specifically measure the zinc content of proteins in a high throughput manner. This assay will then be used to identify all of the zinc-binding proteins in a yeast expression library. These methods should identify novel metalloproteins that have a variety of functions, including: metalloenzymes, transcription factors, and metalloregulatory proteins. Together these data will provide information essential for de novo design of metalloenzymes, for comprehending the function of novel zinc enzymes, for interpreting the in vivo roles of metal ions, for understanding zinc metal homeostasis and human zinc deficiency, and for designing active site inhibitors. In particular, inhibitors of protein farnesyltransferase and LpxC deacetylase in the lipid A pathway may be useful as chemotherapeutics (inhibitors are currently in clinical trials) and antibacterial agents, respectively. Novel antibiotics useful for the treatment of Pseudomonas aeruginosa would be particularly beneficial for patients with AIDS or cystic fibrosis.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM040602-16
Application #
6630296
Study Section
Special Emphasis Panel (ZRG1-SSS-B (01))
Program Officer
Ikeda, Richard A
Project Start
1988-07-01
Project End
2005-08-31
Budget Start
2003-09-01
Budget End
2004-08-31
Support Year
16
Fiscal Year
2003
Total Cost
$294,450
Indirect Cost
Name
University of Michigan Ann Arbor
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
073133571
City
Ann Arbor
State
MI
Country
United States
Zip Code
48109
Castañeda, Carol Ann; Wolfson, Noah A; Leng, Katherine R et al. (2017) HDAC8 substrate selectivity is determined by long- and short-range interactions leading to enhanced reactivity for full-length histone substrates compared with peptides. J Biol Chem 292:21568-21577
Niu, Shuai; Kim, Byung Chul; Fierke, Carol A et al. (2017) Ion Mobility-Mass Spectrometry Reveals Evidence of Specific Complex Formation between Human Histone Deacetylase 8 and Poly-r(C)-binding Protein 1. Int J Mass Spectrom 420:9-15
Lopez, Jeffrey E; Haynes, Sarah E; Majmudar, Jaimeen D et al. (2017) HDAC8 Substrates Identified by Genetically Encoded Active Site Photocrosslinking. J Am Chem Soc 139:16222-16227
Castaneda, Carol Ann; Lopez, Jeffrey E; Joseph, Caleb G et al. (2017) Active Site Metal Identity Alters Histone Deacetylase 8 Substrate Selectivity: A Potential Novel Regulatory Mechanism. Biochemistry 56:5663-5670
Temple, Kayla J; Wright, Elia N; Fierke, Carol A et al. (2016) Synthesis of Non-natural, Frame-Shifted Isoprenoid Diphosphate Analogues. Org Lett 18:6038-6041
Temple, Kayla J; Wright, Elia N; Fierke, Carol A et al. (2016) Exploration of GGTase-I substrate requirements. Part 2: Synthesis and biochemical analysis of novel saturated geranylgeranyl diphosphate analogs. Bioorg Med Chem Lett 26:3503-7
Bergom, Carmen; Hauser, Andrew D; Rymaszewski, Amy et al. (2016) The Tumor-suppressive Small GTPase DiRas1 Binds the Noncanonical Guanine Nucleotide Exchange Factor SmgGDS and Antagonizes SmgGDS Interactions with Oncogenic Small GTPases. J Biol Chem 291:6534-45
Gantt, Sister M Lucy; Decroos, Christophe; Lee, Matthew S et al. (2016) General Base-General Acid Catalysis in Human Histone Deacetylase 8. Biochemistry 55:820-32
López, Jeffrey E; Sullivan, Eric D; Fierke, Carol A (2016) Metal-dependent Deacetylases: Cancer and Epigenetic Regulators. ACS Chem Biol 11:706-16
Jennings, Benjamin C; Danowitz, Amy M; Wang, Yen-Chih et al. (2016) Analogs of farnesyl diphosphate alter CaaX substrate specificity and reactions rates of protein farnesyltransferase. Bioorg Med Chem Lett 26:1333-6

Showing the most recent 10 out of 50 publications